The company opened a sprawling space on New York City's 99 Madison Avenue and is planning to open in Riyadh in 2026.

ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

It supports MedTech innovators in bringing products to market and connecting with local manufacturers. MedTech Catapult, a ...

Axplora, a German CDMO that specializes in API small molecule and ADC production, will upgrade its manufacturing facility in ...

The expanded collaboration between BRAIN Biotech and PX Group is a key part of the PX Urban Mining Initiative, an industry and academic network focused on developing and implementing disruptive, ...

says it is building a sustainable biocrude production facility within One North, the former Great Northern Paper Mill location. The plant will be built on an industrial 1,000-acre site of ...

Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate ...

Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...

Furthermore, Legend Biotech’s management has outlined plans for additional manufacturing expansions to meet future demand, underscoring their confidence in reaching production goals by 2025.

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...